home / stock / blue / blue quote
Last: | $0.9143 |
---|---|
Change Percent: | 0.0% |
Open: | $0.9261 |
Close: | $0.9143 |
High: | $0.9584 |
Low: | $0.91 |
Volume: | 3,537,632 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.9143 | $0.9261 | $0.9143 | $0.9584 | $0.91 | 3,537,632 | 07-04-2024 |
$0.9143 | $0.9261 | $0.9143 | $0.9584 | $0.91 | 3,532,455 | 07-03-2024 |
$0.9231 | $0.9753 | $0.9231 | $0.98 | $0.92 | 4,476,623 | 07-02-2024 |
$0.9753 | $0.9682 | $0.9753 | $1.01 | $0.96 | 4,918,213 | 07-01-2024 |
$0.9842 | $0.947 | $0.9842 | $1 | $0.9147 | 8,529,836 | 06-28-2024 |
$0.9487 | $0.9 | $0.9487 | $1 | $0.9 | 9,758,692 | 06-27-2024 |
$0.9072 | $0.97 | $0.9072 | $0.98 | $0.8979 | 4,559,306 | 06-26-2024 |
$0.9478 | $0.998 | $0.9478 | $1.01 | $0.9475 | 5,744,549 | 06-25-2024 |
$1.02 | $0.91 | $1.02 | $1.04 | $0.9 | 10,514,573 | 06-24-2024 |
$0.8991 | $0.8722 | $0.8991 | $0.9217 | $0.8632 | 7,942,620 | 06-21-2024 |
$0.8537 | $0.9106 | $0.8537 | $0.9106 | $0.845 | 10,570,026 | 06-20-2024 |
$0.9106 | $0.94 | $0.9106 | $0.9522 | $0.87 | 8,934,886 | 06-19-2024 |
$0.9106 | $0.94 | $0.9106 | $0.9522 | $0.87 | 8,934,886 | 06-18-2024 |
$0.9522 | $0.951 | $0.9522 | $1.01 | $0.93735 | 7,132,011 | 06-17-2024 |
$0.9596 | $1.01 | $0.9596 | $1.01 | $0.9405 | 6,540,782 | 06-14-2024 |
$1 | $0.995 | $1 | $1.03 | $0.9801 | 2,110,652 | 06-13-2024 |
$0.9887 | $1 | $0.9887 | $1.05 | $0.9669 | 6,345,954 | 06-12-2024 |
$0.9873 | $0.9001 | $0.9873 | $1 | $0.8912 | 5,872,853 | 06-11-2024 |
$0.9327 | $0.9246 | $0.9327 | $0.9403 | $0.88 | 5,723,022 | 06-10-2024 |
$0.905 | $0.9 | $0.905 | $0.9286 | $0.8867 | 3,860,721 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
The downtrodden biotech space has kicked off the second half of 2022 with a boom. Hard-hit gene-editing and gene therapy companies in particular have started the back half of the year on the right foot. Underscoring this point, Bluebird Bio (NASDAQ: BLUE) stock has already risen by ...
Bluebird Bio 's (NASDAQ: BLUE) stock motored upward above 24% amid an unusually high volume of trading before pulling back to around 13.3% by noon on Tuesday, likely as a result of a short squeeze . More than 34.6% of its floating shares were held short as of June 15, which puts...